NO994997L - Alkaloidhalidsalter av swainsonin og fremgangsmåter ved anvendelse - Google Patents

Alkaloidhalidsalter av swainsonin og fremgangsmåter ved anvendelse

Info

Publication number
NO994997L
NO994997L NO994997A NO994997A NO994997L NO 994997 L NO994997 L NO 994997L NO 994997 A NO994997 A NO 994997A NO 994997 A NO994997 A NO 994997A NO 994997 L NO994997 L NO 994997L
Authority
NO
Norway
Prior art keywords
swainsonine
methods
alkaloid
halide salts
salts
Prior art date
Application number
NO994997A
Other languages
English (en)
Other versions
NO994997D0 (no
Inventor
James W Dennis
Rajan N Shah
Lothar Ziser
Original Assignee
Glycodesign Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycodesign Inc filed Critical Glycodesign Inc
Publication of NO994997D0 publication Critical patent/NO994997D0/no
Publication of NO994997L publication Critical patent/NO994997L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Krystallinske salter av swainsonin, og fremgangsmåter som anvender de samme.
NO994997A 1997-04-15 1999-10-14 Alkaloidhalidsalter av swainsonin og fremgangsmåter ved anvendelse NO994997L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84055997A 1997-04-15 1997-04-15
US7642698P 1998-02-24 1998-02-24
PCT/CA1998/000360 WO1998046602A1 (en) 1997-04-15 1998-04-15 Alkaloid halide salts of swainsonine and methods of use

Publications (2)

Publication Number Publication Date
NO994997D0 NO994997D0 (no) 1999-10-14
NO994997L true NO994997L (no) 1999-12-14

Family

ID=26758089

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994997A NO994997L (no) 1997-04-15 1999-10-14 Alkaloidhalidsalter av swainsonin og fremgangsmåter ved anvendelse

Country Status (12)

Country Link
EP (1) EP0975632B1 (no)
JP (1) JP2001518902A (no)
KR (1) KR20010006423A (no)
CN (1) CN1260796A (no)
AT (1) ATE226204T1 (no)
AU (1) AU743625B2 (no)
BR (1) BR9808585A (no)
DE (1) DE69808745D1 (no)
IL (1) IL132344A0 (no)
NO (1) NO994997L (no)
NZ (1) NZ500671A (no)
WO (1) WO1998046602A1 (no)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5973519A (ja) * 1982-09-17 1984-04-25 Fujisawa Pharmaceut Co Ltd スワインソニンの製造法およびそれを含む免疫調整剤
AU2873292A (en) * 1991-11-06 1993-06-07 Toronto Research Chemicals Inc. Immunostimulating swainsonine analogs

Also Published As

Publication number Publication date
NZ500671A (en) 2000-07-28
AU743625B2 (en) 2002-01-31
JP2001518902A (ja) 2001-10-16
CN1260796A (zh) 2000-07-19
NO994997D0 (no) 1999-10-14
KR20010006423A (ko) 2001-01-26
WO1998046602A1 (en) 1998-10-22
BR9808585A (pt) 2001-07-31
EP0975632A1 (en) 2000-02-02
IL132344A0 (en) 2001-03-19
ATE226204T1 (de) 2002-11-15
DE69808745D1 (de) 2002-11-21
AU7020698A (en) 1998-11-11
EP0975632B1 (en) 2002-10-16

Similar Documents

Publication Publication Date Title
FI956074A0 (fi) Asetyylikolinesteraasin inhibiittoreina toimivia 1-asemasta substituoituja isatiini- ja oksindolijohdannaisia
DK1475377T3 (da) Indol-derivater og deres anvendelse som inhibitorer for phosphodiesterase 4
MY138239A (en) Nitrogen containing heterobicycles as factor xa inhibitors
NO986103D0 (no) Substituerte indazol-derivater og deres anvendelse som fosfodiesterase (PDE
EP0987263A3 (en) Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors
DK125796A (da) I form af små molekyler foreliggende inhibitorer for rotamaseaktivitet
TR199903098T2 (xx) �midozil-siklik asetaller
DE69718480T2 (de) Heterocyclische metalloprotease inhibitoren
NO980720D0 (no) Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling
DK0923561T3 (da) Heterocykliske metalloproteaseinhibitorer
DK0946512T3 (da) 6-Phenylpyridyl-2-aminderivater, der er nyttige som NOS-inhibitorer
DK0950657T3 (da) Substituerede carbazoler, fremgangsmåde til deres fremstilling og deres anvendelse som sPLA2-inhibitorer
NO923089D0 (no) Tetrahydroindazol, tetrahydrocyklopentapyrazol og heksahydrocykloheptapyrazol forbindelser og deres anvendelse som hmg-coa reduktase-hemmere
EA200001129A3 (ru) Способ получения 4-карбоксиамино-2-замещенного-1,2,3,4-тетрагидрохинолина
ES2188983T3 (es) Nuevas benzofuran-4-carboxamidas.
NO980178D0 (no) Cyklo-oksygenase-inhibitor og amidin-derivatsalter, fremgangsmåte for fremstilling derav, anvendelse derav som legemidler, og farmasöytiske blandinger inneholdende slike derivater
DK0892796T3 (da) Isatinderivater som acetylcholinesteraseinhibitorer og analgetika
NO931040D0 (no) Indol- og indazolderivater, fremgangsmaate til fremstilling og anvendelse derav
NO20003615L (no) FremgangsmÕte for korreksjon av brønn-loggedata
NO985307L (no) Distamycinderivater, fremgangsmÕte for deres fremstilling, og deres anvende
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
NO990913D0 (no) Naftylforbindelser, intermediater, sammensetninger og metoder for anvendelse
AP2001002045A0 (en) FKBP inhibitors.
ATE337320T1 (de) Indolderivate als pde5-inhibitoren
NO994997L (no) Alkaloidhalidsalter av swainsonin og fremgangsmåter ved anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application